Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.1601 USD
0.69%
Updated:
Apr 30, 2024
Sonoma Pharmaceuticals Inc
Operating Expenses
|
Sonoma Pharmaceuticals Inc
Operating Expenses Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Operating Expenses
-$9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
5%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Expenses
-$34.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Expenses
-$23.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-11%
|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Expenses
-$27.6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Expenses
-$40.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-8%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Expenses
-$16.7B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-3%
|
See Also
What is Sonoma Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-9m
USD
-9m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Operating Expenses amounts to -9m USD.
What is Sonoma Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
5%
5%
Over the last year, the Operating Expenses growth was 12%. The average annual Operating Expenses growth rates for Sonoma Pharmaceuticals Inc have been 10% over the past three years , 16% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
